CSA-13

N/A

Report date: 2025/11/18 13:59:13
NME

Base Information

Drug NameCSA-13
Drug Alias NameCSA-13
ClassificationSmall molecules > Steroids
Mechanisms of ActionCell membrane permeability enhancersInhibitor of nuclear factor kappa-B kinase subunit beta inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit beta
Therapy Area/IndicationsVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBrigham Young University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrigham Young University
Active IndicationsN/A
Inactive IndicationsVirus DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A